Coronavirus Update: BARDA Funding Rises To $955m As Moderna Expands Phase III Trial

30,000 Recruitment Target For All US-Sponsored Trials

 
• By Scrip Team
  
Moderna_Pills_Syringe
Moderna has said the first millions of doses of its vaccine could be ready for Thanksgiving in late November.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip